{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:46:42Z","timestamp":1790282802717,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.humpath.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T03:23:52Z","timestamp":1714015432000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Primary leptomeningeal melanocytic neoplasms: A clinicopathologic, immunohistochemical, and molecular study of 12 cases"],"prefix":"10.1016","volume":"148","author":[{"given":"Jiao-jie","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-lan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-bing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-yi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.04.014_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jocn.2010.01.017","article-title":"Primary melanocytic neoplasms of the central nervous system","volume":"17","author":"Liubinas","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.humpath.2024.04.014_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bpa.12241","article-title":"Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects","volume":"25","author":"K\u00fcsters-Vandevelde","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib3","series-title":"Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma. WHO classification of tumours, 5th edition: central nervous system tumours","first-page":"344","author":"Gessi","year":"2021"},{"key":"10.1016\/j.humpath.2024.04.014_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00401-012-0948-x","article-title":"GNAQ and GNA11 mutations in melanocytomas of the central nervous system","volume":"123","author":"Murali","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib5","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-18-0763","article-title":"Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA Methylation Profiling","volume":"24","author":"Griewank","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2024.04.014_bib6","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.jid.2017.04.022","article-title":"Activating CYSLTR2 and PLCB4 mutations in primary leptomeningeal melanocytic tumors","volume":"137","author":"Van De Nes","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2024.04.014_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-016-0272-0","article-title":"SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas","volume":"4","author":"K\u00fcsters-Vandevelde","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.humpath.2024.04.014_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-009-0611-3","article-title":"Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system","volume":"119","author":"K\u00fcsters-Vandevelde","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bpa.12228","article-title":"Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles","volume":"25","author":"K\u00f6elsche","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2990.2012.01288.x","article-title":"GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system","volume":"39","author":"Gessi","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.humpath.2024.04.014_bib11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/nan.12138","article-title":"Absence of TERT promoter mutations in primary melanocytic tumours of the central nervous system","volume":"40","author":"Gessi","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.humpath.2024.04.014_bib12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00000478-199907000-00001","article-title":"Primary melanocytic neoplasms of the central nervous systems","volume":"23","author":"Brat","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/cac2.12372","article-title":"Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract","volume":"42","author":"Wu","year":"2022","journal-title":"Cancer Commun"},{"key":"10.1016\/j.humpath.2024.04.014_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/atm-21-4235","article-title":"BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center","volume":"10","author":"Ren","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.humpath.2024.04.014_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.humpath.2024.04.014_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1148\/rg.295095109","article-title":"Pigmented lesions of the central nervous system: radiologic-pathologic correlation","volume":"29","author":"Smith","year":"2009","journal-title":"Radiographics"},{"key":"10.1016\/j.humpath.2024.04.014_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2007.12.7837","article-title":"Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials","volume":"26","author":"Korn","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.04.014_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2004-816266","article-title":"Primary melanocytic lesions of the CNS: report of five cases","volume":"65","author":"Freudenstein","year":"2004","journal-title":"Zentralbl Neurochir"},{"key":"10.1016\/j.humpath.2024.04.014_bib21","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1200\/JCO.2010.34.0695","article-title":"Primary melanoma of the spinal cord: a case report, molecular footprint, and review of the literature","volume":"29","author":"Fuld","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.04.014_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11060-015-2052-2","article-title":"Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system","volume":"127","author":"Van De Nes","year":"2016","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.humpath.2024.04.014_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00313020902915875","article-title":"Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation","volume":"41","author":"Morey","year":"2009","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2024.04.014_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235851","article-title":"How Should We Treat meningeal melanocytoma? A retrospective analysis of Potential treatment Strategies","volume":"14","author":"Ricchizzi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.04.014_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1684\/ejd.2016.2828","article-title":"Primary leptomeningeal melanocytic tumour with a plaque-like blue nevus in a patient with ocular albinism","volume":"26","author":"Goldman-Levy","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.humpath.2024.04.014_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0317167100022150","article-title":"Plaque-type blue nevus with meningeal melanocytomas","volume":"39","author":"Zeiler","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.humpath.2024.04.014_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2024.04.014_bib28","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2024.04.014_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.humpath.2024.04.014_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical Subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2024.04.014_bib31","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.humpath.2024.04.014_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2024.04.014_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2024.04.014_bib34","doi-asserted-by":"crossref","first-page":"40683","DOI":"10.18632\/oncotarget.16542","article-title":"Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations","volume":"8","author":"Cosgarea","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2024.04.014_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"Powering Precision Medicine through an International Consortium","volume":"7","year":"2017","journal-title":"Cancer Discov"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T07:03:05Z","timestamp":1715238185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"alternative-id":["S0046817724000662"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.04.014","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary leptomeningeal melanocytic neoplasms: A clinicopathologic, immunohistochemical, and molecular study of 12 cases","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}